Caligan Partners LP reports

Company location: New York, NY
Fiscal year end: 31 December

Caligan Partners LP has filed 126 SEC EDGAR filings since 11 Mar 2019

SEC filing history

Showing 51-75 of 126 matching filings.

Per page

25

Current page

3

4 File 001-39724

4 filing

Filing date: 14 Dec 2023
Reporting date: 14 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

LIQUIDIA CORPORATION

Filing date: 14 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 29 Nov 2023
Reporting date: 27 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34703

4 filing

Filing date: 15 Sep 2023
Reporting date: 14 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ANIKA THERAPEUTICS, INC.

Filing date: 11 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34703

4 filing

Filing date: 17 Aug 2023
Reporting date: 15 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

ANIKA THERAPEUTICS, INC.

Filing date: 17 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-34703

3 filing

Filing date: 11 Aug 2023
Reporting date: 01 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 03 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 03 Jul 2023
Reporting date: 29 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

STANDARD BIOTOOLS, INC.

Filing date: 03 Jul 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 21 Jun 2023
Reporting date: 19 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 000-30235

3 filing

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

EXELIXIS, INC.

Filing date: 02 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 18 May 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR/A File 028-23096

13F-HR/A filing

Filing date: 15 May 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 15 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 06 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRRN14A

ANIKA THERAPEUTICS, INC.

Filing date: 06 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PREC14A

ANIKA THERAPEUTICS, INC.

Filing date: 30 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 28 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

EXELIXIS, INC.

Filing date: 27 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .